Publication date: Sep 04, 2023
The SARS-CoV-2 Nsp8 protein is a critical component of the RNA replicase, as its N-terminal domain (NTD) anchors Nsp12, the RNA, and Nsp13. Whereas its C-terminal domain (CTD) structure is well resolved, there is an open debate regarding the conformation adopted by the NTD as it is predicted as disordered but found in a variety of complex-dependent conformations or missing from many other structures. Using NMR spectroscopy, we show that the SARS CoV-2 Nsp8 NTD features both well folded secondary structure and disordered segments. Our results suggest that while part of this domain corresponding to two long α-helices forms autonomously, the folding of other segments would require interaction with other replicase components. When isolated, the α-helix population progressively declines towards the C-termini but surprisingly binds dsRNA while preserving structural disorder.
Open Access PDF
Concepts | Keywords |
---|---|
Anchors | Binds |
Disorder | Cov |
Nsp12 | Critical |
Proteins | Disordered |
Spectroscopy | Domain |
Dsrna | |
Folds | |
Nsp8 | |
Ntd | |
Replicase | |
Sars | |
Segments | |
Terminal |
Semantics
Type | Source | Name |
---|---|---|
disease | VO | population |
drug | DRUGBANK | Coenzyme M |
disease | MESH | COVID 19 pandemic |
drug | DRUGBANK | BV1 |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Tacrine |
disease | IDO | production |
drug | DRUGBANK | Thioredoxin |
drug | DRUGBANK | Histidine |
disease | IDO | site |
drug | DRUGBANK | Isopropyl beta-D-thiogalactopyranoside |
disease | VO | protocol |
drug | DRUGBANK | Dextrose unspecified form |
drug | DRUGBANK | Imidazole |
drug | DRUGBANK | Flunarizine |
drug | DRUGBANK | Sodium lauryl sulfate |
drug | DRUGBANK | Pirenzepine |
drug | DRUGBANK | Indoleacetic acid |
disease | IDO | process |
disease | VO | URE |
drug | DRUGBANK | Esomeprazole |
drug | DRUGBANK | Proline |
drug | DRUGBANK | Pentaerythritol tetranitrate |
drug | DRUGBANK | Ademetionine |
drug | DRUGBANK | Gold |
drug | DRUGBANK | Acetylcholine |
disease | IDO | replication |
drug | DRUGBANK | Erythropoietin |
disease | IDO | facility |
disease | IDO | cell |
disease | VO | efficient |
drug | DRUGBANK | Amber |
disease | MESH | dissociation |